USANA Health Sciences (USNA) Misses Q2 EPS by 17c; Lowers Outlook, $100M Buyback
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% as AI buildout costs, Fed rate outlook weigh
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
USANA Health Sciences Reports Second Quarter Financial Results
July 25, 2017 4:17 PM EDTSecond quarter net sales were $257.1 million, a decrease of 0.6% year-over-year, but up 2.3% in constant currency Number of active Customers1 at quarter end increased 1.8% to 567,000 Second quarter EPS of $0.93, or $0.98 excluding incremental expense related to the Companys internal investigation of its China operations disclosed in February 2017 Company revises 2017 Outlook Share repurchase authorization increased to $100 million
SALT LAKE CITY--(BUSINESS WIRE)-- USANA Health Sciences, Inc. (NYSE: USNA) today announced financial... More
